NDC 70518-0174-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0174
- Requested NDC
- 70518-0174-01
- Package NDCs from labels
- 70518-0174-0, 70518-0174-1, 70518-0174-2, 70518-0174-3, 70518-0174-4, 70518-0174-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | REMEDYREPACK INC. | 2026-06-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0174-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 25 | |
| 70518-0174-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 | |
| 70518-0174-2 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 25 | |
| 70518-0174-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 25 | |
| 70518-0174-4 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0174 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 21 | Current NDC, Legacy NDC, 5 package rows | 20250424_408e797a-2cf3-4ee6-9f9b-179a8cf3d799.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Bryant Ranch Prepack | 5885b1ff-715c-4f90-b43d-bddf94d61acd | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 197887 E7199S1YWR 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 94cd40a1-65bc-4b1b-bb05-cec93bc96502 | 2023-11-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Bryant Ranch Prepack | 1990af86-e9ec-48b8-b354-8456d6d80e0a | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 197887 E7199S1YWR 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Viona Pharmaceuticals Inc | 9925ab75-e3b7-43b7-888e-a2c8763240ba | 2023-10-31 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 3131809e-885a-42d3-b6ad-1b208fd3ba56 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 89ce2fb1-330c-45f9-bd37-b402feea9378 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 27b8f965-d73f-411c-aae6-bcae6e281113 | 2023-10-23 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | d6b933c6-f5f8-406a-84d6-b22c6040482a | 2023-10-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 24cba606-263f-46dc-a4dc-fddc729c0f4b | 2023-10-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | a79a034d-7bbb-4b05-b8fc-8ebf09f33c0c | 2023-10-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 9dd2f58b-d143-4d0c-a298-6d9390e6187a | 2023-10-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 51b0aed8-a229-4d2c-8fdf-aa957fddc41b | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ba452478-f40c-446e-b61d-388379a55efd | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | 719c4db7-ccbe-4779-baa7-a3c461f3aa52 | 2023-09-12 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b9e1bed7-fef9-434a-92f9-b70941176e3e | 2023-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | 1af80800-e7a5-42e5-aa6c-3f61aff4a77b | 2023-08-31 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Pharmaceuticals (USA) Inc. | fa69eeb8-ec82-4be1-8cb7-f64094ed957c | 2023-08-26 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb00980-eeea-4722-b010-e208f3ec2214 | 2023-08-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | 021831ab-dfeb-40fc-aede-4aa1fbb8d918 | 2023-08-18 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.